Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 761 (miR-761) is a small, non-coding RNA involved in post-transcriptional regulation of gene expression by binding to the 3’ untranslated regions of multiple target mRNAs, resulting in translational repression or mRNA degradation[5]. It functions as a regulatory molecule with highly context-dependent effects, acting as a tumor suppressor in some cancers (such as osteosarcoma and certain gastric cancers by downregulating FGFR1 or RIN1, respectively) and as an oncogene in others (such as non-small cell lung cancer and hepatocellular carcinoma)[1][2][3][6]. miR-761’s manipulation can affect cell proliferation, apoptosis, migration, and invasion, and its dysregulation is associated with several types of malignancies. No direct drugs currently target miR-761, but its modulation is considered a potential therapeutic strategy in cancer[2][5][6].
Antisense oligonucleotides or mimics may restore or inhibit miR-761 function to regulate oncogenic or tumor suppressor pathways[2]. Regulation of gene targets (e.g., RIN1, FGFR1, Rab3D, GSK3β) via binding to their 3′ untranslated regions, affecting translation or mRNA stability[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 761 (miR-761).